Published in Ann Surg Oncol on January 01, 1997
Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg (1999) 1.21
Thymoma masquerading as transfusion dependent anemia. Indian J Med Paediatr Oncol (2017) 0.75
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49
Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer (1996) 2.23
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol (1989) 1.81
Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy (1999) 1.76
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75
Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg (1996) 1.69
Options in the management of esophageal perforation: analysis over a 12-year period. Dis Esophagus (2009) 1.63
The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. J Immunol (1981) 1.53
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol (1989) 1.44
Magnetic resonance imaging of normal and pathological white matter maturation. Pediatr Radiol (1988) 1.43
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
The full-scale PACS archive. A prerequisite for the filmless hospital. Acta Radiol (1996) 1.39
Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants adsorbed to antigen-presenting cells during rosette formation with sheep erythrocytes. J Exp Med (1982) 1.37
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33
New developments in the treatment of gastric carcinoma. Semin Oncol (1990) 1.32
[Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?]. Zentralbl Chir (2003) 1.26
Semantic networks of English. Cognition (1991) 1.25
Prognostic factors of resected adenocarcinoma of the esophagus. Surgery (1995) 1.24
Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg (1997) 1.23
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer. Ann Oncol (2000) 1.17
Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol (2005) 1.16
Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol (1998) 1.15
Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol (1989) 1.10
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol (2008) 1.08
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol (2004) 1.06
A mediastinal tumor simulated by a sacculated aneurysm of the azygos vein. Thorac Cardiovasc Surg (1989) 1.06
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg (1996) 1.05
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg (2010) 1.04
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer (2001) 1.03
Surgical resection for cancer of the cardia. Semin Surg Oncol (1999) 1.02
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. Br J Cancer (2000) 1.02
Pulmonary nodule caused by an alveolar adenoma of the lung. Virchows Arch (1997) 1.02
Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer (1994) 1.01
Right hemihepatectomy for bile duct injury following laparoscopic cholecystectomy. Surg Endosc (2003) 1.00
Gastric Cancer. Curr Probl Surg (1997) 1.00
Castleman's disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants. Histopathology (1994) 0.99
Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum. Histopathology (1991) 0.99
Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am J Clin Pathol (1990) 0.99
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer. J Infus Chemother (1996) 0.98
Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities. Int J Cancer (1999) 0.97
The modified AFP score: an attempt to make the results of anti-reflux surgery comparable. Br J Surg (1991) 0.96
Spiral CT angiography and 3D reconstruction in patients with aortic coarctation. Eur Radiol (1997) 0.95
Receptor sites for aggregated gammaglobulin (AGG) on lymphocytes in lymphoproliferative diseases. Br J Haematol (1974) 0.94
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer (2004) 0.94
[Classification of lympho-proliferative diseases using lymphocyte tracers]. Verh Dtsch Ges Inn Med (1975) 0.94
Return of interdigestive motor complex after abdominal surgery. End of postoperative ileus? Dig Dis Sci (1991) 0.94
Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg (1995) 0.92
Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J Pathol (1996) 0.91
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer (1994) 0.91
An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. Lung Cancer (1999) 0.91
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk. Invest New Drugs (1990) 0.91
Prognostic factors in resected primary small bowel tumors. Dig Surg (1998) 0.91
Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol (2012) 0.91
High-volume centers--effect of case load on outcome in cancer surgery. Onkologie (2004) 0.90
New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology (2001) 0.90
Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma. Br J Cancer (1999) 0.90
Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. Clin Cancer Res (1998) 0.89
P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus. Clin Cancer Res (2000) 0.89
Intrapulmonary teratoma 10 years after removal of a mediastinal teratoma in a young man. Thorax (1983) 0.89
Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol (2009) 0.88
Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am (2000) 0.88
Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma. Clin Cancer Res (2000) 0.88
[Diagnosis of and therapy for gastric cancer--work-flow]. Zentralbl Chir (2009) 0.87
Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes. Cancer (1999) 0.87
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities. Clin Cancer Res (1998) 0.87
Coincidence of nutritional habits and esophageal cancer in Germany. Onkologie (2001) 0.87
Delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase, the multienzyme integrating the four primary reactions in beta-lactam biosynthesis, as a model peptide synthetase. Biotechnology (N Y) (1993) 0.87
Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol (2002) 0.87
[How safe is high intrathoracic esophagogastrostomy?]. Chirurg (2003) 0.87
Correlation of content of B cells and Leu7-positive cells with subtype and stage in lymphocyte predominance type Hodgkin's disease. J Cancer Res Clin Oncol (1988) 0.86
Aneurysm clips made of titanium: magnetic characteristics and artifacts in MR. AJNR Am J Neuroradiol (1997) 0.85
Preoperative chemotherapy for unresectable gastric cancer. World J Surg (1995) 0.85
Anterior cervical spine fusion using RABEA-Titan-Cages avoiding iliac crest spongiosa: first experiences and results. Neurol Neurochir Pol (2000) 0.85
[T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases]. Schweiz Med Wochenschr (1974) 0.85
MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int J Cancer (2013) 0.85
Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia. J Gastrointest Surg (2006) 0.85
[Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University]. Chirurg (1992) 0.84
Follicular dendritic cells have prognostic relevance in Hodgkin's disease. Am J Clin Pathol (1994) 0.84
FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding. Nuklearmedizin (2005) 0.84
Chemotherapy in advanced pancreatic adenocarcinoma. Cancer Treat Rev (1998) 0.84
Thoracoscopic enucleation of esophageal leiomyomas: a feasible and safe procedure. Endoscopy (2007) 0.84
PCR-based assays for the detection of monoclonality in non-Hodgkin's lymphoma: application to formalin-fixed, paraffin-embedded tissue and decalcified bone marrow samples. J Mol Med (Berl) (1995) 0.84
Prognostic differences between early squamous-cell and adenocarcinoma of the esophagus. Dis Esophagus (1997) 0.84
The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology (1999) 0.83
Letter: B lymphocytes in the thymus of patients with myasthenia gravis. N Engl J Med (1975) 0.83
Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg (2008) 0.83
Pitfalls in intraoperative frozen section histology of mediastinal neoplasms. Eur J Cardiothorac Surg (1990) 0.83
Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus. Clin Cancer Res (1998) 0.83
Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer: do they have prognostic impact? Int J Colorectal Dis (2012) 0.83